Sinovac Biotech SVA
NASDAQ SVA
$6.47 +0.00 (+0.00%)
At close: Oct 14, 2026 · 4:00 PM EDT

Sinovac Biotech (SVA) Finished Goods (2011 - 2025)

Updated

Sinovac Biotech's Finished Goods was $29.59 million in Q4 2025, up 4.6% from $28.28 million a year earlier.

Analysis

Sinovac Biotech (SVA) Finished Goods (2011 - 2025) Analysis & Trends

From Q4 2011 onward, Sinovac Biotech has reported Finished Goods for 13 quarters.

  • Finished Goods shows a five-year compound annual growth rate of 4.0% (FY2020 to FY2025).
  • In earlier years, Finished Goods was $28.28 million in FY2024 (-18.3%), $34.59 million in FY2023 (-25.1%), $46.17 million in FY2022 (-66.5%) and $138.03 million in FY2021 (+468.2%).
  • The Q4 2025 figure marks the highest quarterly Finished Goods since Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,171.23 Bn 1,139.82 Bn 19.71 Bn
2 Johnson & Johnson 648.76 Bn 568.62 Bn 17.30 Bn
3 AbbVie 503.78 Bn 476.89 Bn 12.70 Bn
4 Merck 366.20 Bn 320.58 Bn 12.21 Bn
5 Novartis Ag 303.55 Bn 267.54 Bn 11.24 Bn
6 Astrazeneca 269.42 Bn 243.11 Bn 12.86 Bn
7 Amgen 242.43 Bn 197.83 Bn 7.24 Bn
8 Gilead Sciences 195.01 Bn 169.21 Bn 6.22 Bn
9 Pfizer 172.42 Bn 119.07 Bn 10.94 Bn
10 Sinovac Biotech 464.94 Mn -35.05 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 29.59 Mn
Dec 31, 2024 28.28 Mn
Dec 31, 2023 34.59 Mn
Dec 31, 2022 46.17 Mn
Dec 31, 2021 138.03 Mn
Dec 31, 2020 24.29 Mn
Dec 31, 2019 13.59 Mn
Dec 31, 2018 16.33 Mn
Dec 31, 2017 13.05 Mn
Dec 31, 2014 12.09 Mn
Dec 31, 2013 10.05 Mn
Dec 31, 2012 8.26 Mn
Dec 31, 2011 4.44 Mn
API Access

Sinovac Biotech Finished Goods API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=finished-goods&ticker=SVA&period=max&api_key=YOUR_API_KEY